Molecular epidemiology of meningococci: Application of DNA sequence typing

International Journal of Medical Microbiology

Volumn 300, Issue 7, 2010, Pages 415-420

  Vogel, Ulrich ^a  

^a UNIVERSITY OF WÜRZBURG   (Germany)

Author keywords

Bacterial typing techniques; Database; Disease outbreaks; Meningococcal vaccine; Molecular epidemiology; Neisseria meningitidis

Indexed keywords

GAMMA GLUTAMYLTRANSFERASE;

ANTIBIOTIC RESISTANCE; BACTERIAL TRANSMISSION; BACTERIAL VIRULENCE; BACTERIUM CULTURE; BACTERIUM IDENTIFICATION; CASE REPORT; CLOSTRIDIUM DIFFICILE; DATA BASE; DISEASE SURVEILLANCE; DNA FINGERPRINTING; DNA SEQUENCE; EPIDEMIC; FATALITY; HUMAN; IMMUNITY; INFORMATION PROCESSING; MENINGOCOCCOSIS; MOLECULAR EPIDEMIOLOGY; MORTALITY; NASOPHARYNX; NEISSERIA MENINGITIDIS; NONHUMAN; SEROLOGY; SHORT SURVEY;

BACTERIAL TYPING TECHNIQUES; BASE SEQUENCE; DATABASES, FACTUAL; DISEASE OUTBREAKS; DNA FINGERPRINTING; DNA, BACTERIAL; EUROPE; GENOTYPE; HUMANS; MENINGOCOCCAL INFECTIONS; MOLECULAR EPIDEMIOLOGY; NEISSERIA MENINGITIDIS;

EID: 77957017504     PISSN: 14384221     EISSN: 16180607     Source Type: Journal    
DOI: 10.1016/j.ijmm.2010.04.017     Document Type: Short Survey

References (72)

1. Aguilera J.F., Perrocheau A., Meffre C., Hahne S. Outbreak of serogroup W135 meningococcal disease after the Hajj pilgrimage, Europe, 2000. Emerg. Infect. Dis. 2002, 8:761-767.
2. Aires-de-Sousa M., Boye K., de L.H., Deplano A., Enright M.C., Etienne J., Friedrich A., Harmsen D., Holmes A., Huijsdens X.W., Kearns A.M., Mellmann A., Meugnier H., Rasheed J.K., Spalburg E., Strommenger B., Struelens M.J., Tenover F.C., Thomas J., Vogel U., Westh H., Xu J., Witte W. High interlaboratory reproducibility of DNA sequence-based typing of bacteria in a multicenter study. J. Clin. Microbiol. 2006, 44:619-621.
3. Allix-Beguec C., Harmsen D., Weniger T., Supply P., Niemann S. Evaluation and strategy for use of MIRU-VNTRplus, a multifunctional database for online analysis of genotyping data and phylogenetic identification of Mycobacterium tuberculosis complex isolates. J. Clin. Microbiol. 2008, 46:2692-2699.
4. Balmer P., Borrow R., Miller E. Impact of meningococcal C conjugate vaccine in the UK. J. Med. Microbiol. 2002, 51:717-722.
5. Bambini S., Muzzi A., Olcén P., Rappuoli R., Pizza M., Comanducci M. Distribution and genetic variability of three vaccine components in a panel of strains representative of the diversity of serogroup B meningococcus. Vaccine 2009, 27:2794-2803.
6. Beernink P.T., Welsch J.A., Harrison L.H., Leipus A., Kaplan S.L., Granoff D.M. Prevalence of factor H-binding protein variants and NadA among meningococcal group B isolates from the United States: implications for the development of a multicomponent group B vaccine. J. Infect. Dis. 2007, 195:1472-1479.
7. Bille E., Ure R., Gray S.J., Kaczmarski E.B., McCarthy N.D., Nassif X., Maiden M.C., Tinsley C.R. Association of a bacteriophage with meningococcal disease in young adults. PLoS ONE 2008, 3:e3885.
8. Bille E., Zahar J.R., Perrin A., Morelle S., Kriz P., Jolley K.A., Maiden M.C., Dervin C., Nassif X., Tinsley C.R. A chromosomally integrated bacteriophage in invasive meningococci. J. Exp. Med. 2005, 201:1905-1913.
9. Bjune G., Høiby E.A., Grønnesby J.K., Arnesen Ø., Fredriksen J.H., Halstensen A., Holten E., Lindbak A.-K., Nøkleby H., Rosenqvist E., Solberg L.K., Closs O., Eng J., Frøholm L.O., Lystad A., Bakketeig L.S., Hareide B. Effect of outer membrane vesicle vaccine against group B meningococcal disease in Norway. Lancet 1991, 338:1093-1096.
10. Borrow R., Carlone G.M., Rosenstein N., Blake M., Feavers I., Martin D., Zollinger W., Robbins J., Aaberge I., Granoff D.M., Miller E., Plikaytis B., van Alphen L., Poolman J., Rappuoli R., Danzig L., Hackell J., Danve B., Caulfield M., Lambert S., Stephens D. Neisseria meningitidis group B correlates of protection and assay standardization - international meeting report Emory University, Atlanta, Georgia, United States, March 16-17, 2005. Vaccine 2006, 24:5093-5107.
11. Brehony C., Jolley K.A., Maiden M.C. Multilocus sequence typing for global surveillance of meningococcal disease. FEMS Microbiol. Rev. 2007, 31:15-26.
12. Brehony C., Wilson D.J., Maiden M.C. Variation of the factor H-binding protein of Neisseria meningitidis. Microbiology 2009, 155:4155-4169.
13. Buckee C.O., Jolley K.A., Recker M., Penman B., Kriz P., Gupta S., Maiden M.C. Role of selection in the emergence of lineages and the evolution of virulence in Neisseria meningitidis. Proc. Natl. Acad. Sci. U.S.A. 2008, 105:15082-15087.
14. Caugant D.A., Frøholm L.O., Bøvre K., Holten E., Frasch C.E., Mocca L.F., Zollinger W.D., Selander R.K. Intercontinental spread of a genetically distinctive complex of clones of Neisseria meningitidis causing epidemic disease. Proc. Natl. Acad. Sci. U.S.A. 1986, 83:4927-4931.
15. Caugant D.A., Tzanakaki G., Kriz P. Lessons from meningococcal carriage studies. FEMS Microbiol. Rev. 2007, 31:52-63.
16. Chan M.S., Maiden M.C., Spratt B.G. Database-driven multi locus sequence typing (MLST) of bacterial pathogens. Bioinformatics 2001, 17:1077-1083.
17. Claus H., Maiden M.C., Wilson D.J., McCarthy N.D., Jolley K.A., Urwin R., Hessler F., Frosch M., Vogel U. Genetic analysis of meningococci carried by children and young adults. J. Infect. Dis. 2005, 191:1263-1271.
18. Claus H., Stummeyer K., Batzilla J., Mühlenhoff M., Vogel U. Amino acid 310 determines the donor substrate specificity of serogroup W-135 and Y capsule polymerases of Neisseria meningitidis. Mol. Microbiol. 2009, 71:960-971.
19. Elias J., Claus H., Frosch M., Vogel U. Evidence for indirect nosocomial transmission of Neisseria meningitidis resulting in two cases of invasive meningococcal disease. J. Clin. Microbiol. 2006, 44:4276-4278.
20. Elias J., Harmsen D., Claus H., Hellenbrand W., Frosch M., Vogel U. Spatiotemporal analysis of invasive meningococcal disease, Germany. Emerg. Infect. Dis. 2006, 12:1689-1695.
21. Elias J., Vogel U. IS1301 fingerprint analysis of Neisseria meningitidis strains belonging to the ET-15 clone. J. Clin. Microbiol. 2007, 45:159-167.
22. Feavers I.M., Gray S.J., Urwin R., Russell J.E., Bygraves J.A., Kaczmarski E.B., Maiden M.C. Multilocus sequence typing and antigen gene sequencing in the investigation of a meningococcal disease outbreak. J. Clin. Microbiol. 1999, 37:3883-3887.
23. Feavers I.M., Suker J., McKenna A.J., Heath A.B., Maiden M.C. Molecular analysis of the serotyping antigens of Neisseria meningitidis. Infect. Immun. 1992, 60:3620-3629.
24. Feil E.J., Maiden M.C., Achtman M., Spratt B.G. The relative contributions of recombination and mutation to the divergence of clones of Neisseria meningitidis. Mol. Biol. Evol. 1999, 16:1496-1502.
25. Fisher I.S., Threlfall E.J. The Enter-net and Salm-gene databases of foodborne bacterial pathogens that cause human infections in Europe and beyond: an international collaboration in surveillance and the development of intervention strategies. Epidemiol. Infect. 2005, 133:1-7.
26. Fletcher L.D., Bernfield L., Barniak V., Farley J.E., Howell A., Knauf M., Ooi P., Smith R.P., Weise P., Wetherell M., Xie X., Zagursky R., Zhang Y., Zlotnick G.W. Vaccine potential of the Neisseria meningitidis 2086 lipoprotein. Infect. Immun. 2004, 72:2088-2100.
27. Frasch C.E., Chapman S.S. Classification of Neisseria meningitidis group B into distinct serotypes. I. Serological typing by a microbactericidal method. Infect. Immun. 1972, 5:98-102.
28. Frasch C.E., Zollinger W.D., Poolman J.T. Serotype antigens of Neisseria meningitidis and a proposed scheme for designation of serotypes. Rev. Infect. Dis. 1985, 7:504-510.
29. Giuliani M.M., du-Bobie J., Comanducci M., Arico B., Savino S., Santini L., Brunelli B., Bambini S., Biolchi A., Capecchi B., Cartocci E., Ciucchi L., Di M.F., Ferlicca F., Galli B., Luzzi E., Masignani V., Serruto D., Veggi D., Contorni M., Morandi M., Bartalesi A., Cinotti V., Mannucci D., Titta F., Ovidi E., Welsch J.A., Granoff D., Rappuoli R., Pizza M. A universal vaccine for serogroup B meningococcus. Proc. Natl. Acad. Sci. U.S.A. 2006, 103:10834-10839.
30. Goldschneider I., Gotschlich E.C., Artenstein M.S. Human immunity to the meningococcus. II. Development of natural immunity. J. Exp. Med. 1969, 129:1327-1348.
31. Gray S.J., Trotter C.L., Ramsay M.E., Guiver M., Fox A.J., Borrow R., Mallard R.H., Kaczmarski E.B. Epidemiology of meningococcal disease in England and Wales 1993/94 to 2003/04: contribution and experiences of the Meningococcal reference unit. J. Med. Microbiol. 2006, 55:887-896.
32. Grodet C., Dequin P.F., Watt S., Lanotte P., de Gialluly C., Taha M.K., Alonso J.M., Quentin R., Goudeau A., Mereghetti L. Outbreak in France of Neisseria meningitidis B:15:P1.12 belonging to sequence type 1403. Clin. Microbiol. Infect. 2004, 10:845-848.
33. Heckenberg S.G., de Gans J., Brouwer M.C., Weisfelt M., Piet J.R., Spanjaard L., van der Ende A., van de Beek D. Clinical features, outcome, and meningococcal genotype in 258 adults with meningococcal meningitis: a prospective cohort study. Medicine (Baltimore) 2008, 87:185-192.
34. Jacobsson S., Hedberg S.T., Molling P., Unemo M., Comanducci M., Rappuoli R., Olcén P. Prevalence and sequence variations of the genes encoding the five antigens included in the novel 5CVMB vaccine covering group B meningococcal disease. Vaccine 2009, 27:1579-1584.
35. Jacobsson S., Thulin S., Molling P., Unemo M., Comanducci M., Rappuoli R., Olcén P. Sequence constancies and variations in genes encoding three new meningococcal vaccine candidate antigens. Vaccine 2006, 24:2161-2168.
36. Jelfs J., Munro R., Ashton F.E., Caugant D.A. Genetic characterization of a new variant within the ET-37 complex of Neisseria meningitidis associated with outbreaks in various parts of the world. Epidemiol. Infect. 2000, 125:285-298.
37. Jolley K.A., Brehony C., Maiden M.C. Molecular typing of meningococci: recommendations for target choice and nomenclature. FEMS Microbiol. Rev. 2007, 31:89-96.
38. Jolley K.A., Chan M.S., Maiden M.C. mlstdbNet - distributed multi-locus sequence typing (MLST) databases. BMC Bioinformatics 2004, 5:86.
39. Jolley K.A., Feil E.J., Chan M.S., Maiden M.C. Sequence type analysis and recombinational tests (START). Bioinformatics 2001, 17:1230-1231.
40. Jolley K.A., Maiden M.C. AgdbNet - antigen sequence database software for bacterial typing. BMC Bioinformatics 2006, 7:314.
41. Kuijper E.J., Barbut F., Brazier J.S., Kleinkauf N., Eckmanns T., Lambert M.L., Drudy D., Fitzpatrick F., Wiuff C., Brown D.J., Coia J.E., Pituch H., Reichert P., Even J., Mossong J., Widmer A.F., Olsen K.E., Allerberger F., Notermans D.W., Delmee M., Coignard B., Wilcox M., Patel B., Frei R., Nagy E., Bouza E., Marin M., Akerlund T., Virolainen-Julkunen A., Lyytikäinen O., Kotila S., Ingebretsen A., Smyth B., Rooney P., Poxton I.R., Monnet D.L. Update of Clostridium difficile infection due to PCR ribotype 027 in Europe, 2008. Euro Surveill. 2008, 13.
42. Law D.K., Lorange M., Ringuette L., Dion R., Giguere M., Henderson A.M., Stoltz J., Zollinger W.D., De Wals P., Tsang R.S. Invasive meningococcal disease in Quebec, Canada, due to an emerging clone of ST-269 serogroup B meningococci with serotype antigen 17 and serosubtype antigen P1. 19 (B:17:P1. 19). J. Clin. Microbiol. 2006, 44:2743-2749.
43. Lucidarme J., Comanducci M., Findlow J., Gray S.J., Kaczmarski E.B., Guiver M., Kugelberg E., Vallely P.J., Oster P., Pizza M., Bambini S., Muzzi A., Tang C.M., Borrow R. Characterization of fHbp, nhba (gna2132), nadA, porA, sequence type (ST), and genomic presence of IS1301 in group B meningococcal ST269 clonal complex isolates from England and Wales. J. Clin. Microbiol. 2009, 47:3577-3585.
44. Maiden M.C. Multilocus sequence typing of bacteria. Annu. Rev. Microbiol. 2006, 60:561-588.
45. Maiden M.C., Bygraves J.A., Feil E., Morelli G., Russell J.E., Urwin R., Zhang Q., Zhou J., Zurth K., Caugant D.A., Feavers I.M., Achtman M., Spratt B.G. Multilocus sequence typing: a portable approach to the identification of clones within populations of pathogenic microorganisms. Proc. Natl. Acad. Sci. U.S.A. 1998, 95:3140-3145.
46. Maiden M.C., Ibarz-Pavon A.B., Urwin R., Gray S.J., Andrews N.J., Clarke S.C., Walker A.M., Evans M.R., Kroll J.S., Neal K.R., Ala'Aldeen D.A., Crook D.W., Cann K., Harrison S., Cunningham R., Baxter D., Kaczmarski E., Maclennan J., Cameron J.C., Stuart J.M. Impact of meningococcal serogroup C conjugate vaccines on carriage and herd immunity. J. Infect. Dis. 2008, 197:737-743.
47. Murchan S., Kaufmann M.E., Deplano A., de Ryck R., Struelens M., Zinn C.E., Fussing V., Salmenlinna S., Vuopio-Varkila J., El Solh N., Cuny C., Witte W., Tassios P.T., Legakis N., van Leeuwen W., van Belkum A., Vindel A., Laconcha I., Garaizar J., Haeggman S., Olsson-Liljequist B., Ransjo U., Coombes G., Cookson B. Harmonization of pulsed-field gel electrophoresis protocols for epidemiological typing of strains of methicillin-resistant Staphylococcus aureus: a single approach developed by consensus in 10 European laboratories and its application for tracing the spread of related strains. J. Clin. Microbiol. 2003, 41:1574-1585.
48. Murphy E., Andrew L., Lee K.L., Dilts D.A., Nunez L., Fink P.S., Ambrose K., Borrow R., Findlow J., Taha M.K., Deghmane A.E., Kriz P., Musilek M., Kalmusova J., Caugant D.A., Alvestad T., Mayer L.W., Sacchi C.T., Wang X., Martin D., von G.A., du P.M., Klugman K.P., Anderson A.S., Jansen K.U., Zlotnick G.W., Hoiseth S.K. Sequence diversity of the factor H binding protein vaccine candidate in epidemiologically relevant strains of serogroup B Neisseria meningitidis. J. Infect. Dis. 2009, 200:279-289.
49. Olcén P., Fredlund H. Isolation and characterization of Neisseria meningitidis in the vaccine era. Who needs what and when?. Scand. J. Infect. Dis. 2010, 42:4-11.
50. Oster P., Lennon D., O'Hallahan J., Mulholland K., Reid S., Martin D. MeNZB: a safe and highly immunogenic tailor-made vaccine against the New Zealand Neisseria meningitidis serogroup B disease epidemic strain. Vaccine 2005, 23:2191-2196.
51. Reinhardt M., Elias J., Albert J., Frosch M., Harmsen D., Vogel U. EpiScanGIS: an online geographic surveillance system for meningococcal disease. Int. J. Health Geogr. 2008, 7:33.
52. Rosenstein N.E., Perkins B.A., Stephens D.S., Popovic T., Hughes J.M. Meningococcal disease. N. Engl. J. Med. 2001, 344:1378-1388.
53. Russell J.E., Jolley K.A., Feavers I.M., Maiden M.C., Suker J. PorA variable regions of Neisseria meningitidis. Emerg. Infect. Dis. 2004, 10:674-678.
54. Schoen C., Joseph B., Claus H., Vogel U., Frosch M. Living in a changing environment: insights into host adaptation in Neisseria meningitidis from comparative genomics. Int. J. Med. Microbiol. 2007, 297:601-613.
55. Schouls L.M., van der Ende A., Damen M., van de Pol I. Multiple-locus variable-number tandem repeat analysis of Neisseria meningitidis yields groupings similar to those obtained by multilocus sequence typing. J. Clin. Microbiol. 2006, 44:1509-1518.
56. Schrauder A., Claus H., Elias J., Vogel U., Haas W., Hellenbrand W. Capture-recapture analysis to estimate the incidence of invasive meningococcal disease in Germany, 2003. Epidemiol. Infect. 2006, 135:657-664.
57. Slaterus K.W. Serological typing of meningococci by means of micro-precipitation. Antonie Van Leeuwenhoek 1961, 27:305-315.
58. Stephens D.S. Conquering the meningococcus. FEMS Microbiol. Rev. 2007, 31:3-14.
59. Taha M.K., Achtman M., Alonso J.M., Greenwood B., Ramsay M., Fox A., Gray S., Kaczmarski E. Serogroup W135 meningococcal disease in Hajj pilgrims. Lancet 2000, 356:2159.
60. Taha M.K., Vazquez J.A., Hong E., Bennett D.E., Bertrand S., Bukovski S., Cafferkey M.T., Carion F., Christensen J.J., Diggle M., Edwards G., Enriquez R., Fazio C., Frosch M., Heuberger S., Hoffmann S., Jolley K.A., Kadlubowski M., Kechrid A., Kesanopoulos K., Kriz P., Lambertsen L., Levenet I., Musilek M., Paragi M., Saguer A., Skoczynska A., Stefanelli P., Thulin S., Tzanakaki G., Unemo M., Vogel U., Zarantonelli M.L. Target gene sequencing to characterize the penicillin G susceptibility of Neisseria meningitidis. Antimicrob. Agents Chemother. 2007, 51:2784-2792.
61. Thompson E.A., Feavers I.M., Maiden M.C. Antigenic diversity of meningococcal enterobactin receptor FetA, a vaccine component. Microbiology 2003, 149:1849-1858.
62. Trotter C.L., McVernon J., Ramsay M.E., Whitney C.G., Mulholland E.K., Goldblatt D., Hombach J., Kieny M.P. Optimising the use of conjugate vaccines to prevent disease caused by Haemophilus influenzae type b, Neisseria meningitidis and Streptococcus pneumoniae. Vaccine 2008, 26:4434-4445.
63. Tzanakaki G., Kesanopoulos K., Yazdankhah S.P., Levidiotou S., Kremastinou J., Caugant D.A. Conventional and molecular investigation of meningococcal isolates in relation to two outbreaks in the area of Athens, Greece. Clin. Microbiol. Infect. 2006, 12:1024-1026.
64. Urwin R., Russell J.E., Thompson E.A., Holmes E.C., Feavers I.M., Maiden M.C. Distribution of surface protein variants among hyperinvasive meningococci: implications for vaccine design. Infect. Immun. 2004, 72:5955-5962.
65. van Belkum A. Tracing isolates of bacterial species by multilocus variable number of tandem repeat analysis (MLVA). FEMS Immunol. Med. Microbiol. 2007, 49:22-27.
66. van der Ende A., Hopman C.T., Keijzers W.C., Spanjaard L., Lodder E.B., van Keulen P.H., Dankert J. Outbreak of meningococcal disease caused by PorA-deficient meningococci. J. Infect. Dis. 2003, 187:869-871.
67. Vermont C.L., van Dijken H.H., de Groot R., van Alphen L., van den Dobbelsteen G.P. PorA-specific differences in antibody avidity after vaccination with a hexavalent Men B outer membrane vesicle vaccine in toddlers and school children. Vaccine 2004, 22:3008-3013.
68. Vetter N., Matthews I. Principles of epidemiology. Epidemiology and Public Health Medicine 1999, 1-51. Edinburgh, Churchill Livingstone. N. Vetter, I. Matthews (Eds.).
69. Vogel U., Claus H., Frosch M., Caugant D.A. Molecular basis for distinction of the ET-15 clone within the ET- 37 complex of Neisseria meningitidis. J. Clin. Microbiol. 2000, 38:941-942. (letter).
70. Vogel U., Hammerschmidt S., Frosch M. Sialic acids of both the capsule and the sialylated lipooligosaccharide of Neisseria meningitis serogroup B are prerequisites for virulence of meningococci in the infant rat. Med. Microbiol. Immunol. 1996, 185:81-87.
71. Yazdankhah S.P., Kriz P., Tzanakaki G., Kremastinou J., Kalmusova J., Musilek M., Alvestad T., Jolley K.A., Wilson D.J., McCarthy N.D., Caugant D.A., Maiden M.C. Distribution of serogroups and genotypes among disease-associated and carried isolates of Neisseria meningitidis from the Czech Republic, Greece, and Norway. J. Clin. Microbiol. 2004, 42:5146-5153.
72. Zapata G.A., Vann W.F., Rubinstein Y., Frasch C.E. Identification of variable region differences in Neisseria meningitidis class 3 protein sequences among five group B serotypes. Mol. Microbiol. 1992, 6:3493-3499.